GlaxoSmithKline PLC ADR (GSK) — Cash Flow Reinvestment Rate
GlaxoSmithKline PLC ADR (GSK) has a Cash Flow Reinvestment Rate of 0.40x as of March 2026, reinvesting $452.00 Million (capex $443.00 Million plus investments $9.00 Million) from operating cash flow of $1.14 Billion. Explore capital reinvestment ratio of GlaxoSmithKline PLC ADR to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
GlaxoSmithKline PLC ADR Cash Flow Reinvestment Rate (1990–2025)
Historical reinvestment intensity for GlaxoSmithKline PLC ADR across 36 annual periods. Also explore GlaxoSmithKline PLC ADR assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for GlaxoSmithKline PLC ADR (1990–2025)
Year-by-year capital reinvestment analysis for GlaxoSmithKline PLC ADR. For live market cap and broader valuation context, see how much is GlaxoSmithKline PLC ADR worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.19x | $1.33 Billion | $7.14 Billion | $1.32 Billion | ▼ -71.0% |
| 2024 | 0.64x | $4.21 Billion | $6.55 Billion | $2.98 Billion | ▲ +57.0% |
| 2023 | 0.41x | $3.23 Billion | $7.89 Billion | $1.63 Billion | ▼ -72.5% |
| 2022 | 1.49x | $11.03 Billion | $7.40 Billion | $2.26 Billion | ▲ +262.9% |
| 2021 | 0.41x | $3.27 Billion | $7.95 Billion | $2.93 Billion | ▼ -21.2% |
| 2020 | 0.52x | $4.40 Billion | $8.44 Billion | $2.24 Billion | ▼ -44.4% |
| 2019 | 0.94x | $7.52 Billion | $8.02 Billion | $2.16 Billion | ▲ +135.7% |
| 2018 | 0.40x | $3.35 Billion | $8.42 Billion | $1.80 Billion | ▼ -24.5% |
| 2017 | 0.53x | $3.65 Billion | $6.92 Billion | $2.20 Billion | ▼ -5.5% |
| 2016 | 0.56x | $3.62 Billion | $6.50 Billion | $2.35 Billion | ▼ -86.1% |
| 2015 | 4.02x | $10.32 Billion | $2.57 Billion | $1.90 Billion | ▲ +1013.8% |
| 2014 | 0.36x | $1.87 Billion | $5.18 Billion | $1.75 Billion | ▲ +26.2% |
| 2013 | 0.29x | $2.06 Billion | $7.22 Billion | $1.70 Billion | ▼ -17.8% |
| 2012 | 0.35x | $1.52 Billion | $4.38 Billion | $1.52 Billion | ▲ +63.5% |
| 2011 | 0.21x | $1.33 Billion | $6.25 Billion | $1.33 Billion | ▼ -11.7% |
| 2010 | 0.24x | $1.64 Billion | $6.80 Billion | $1.64 Billion | ▲ +0.7% |
| 2009 | 0.24x | $1.87 Billion | $7.84 Billion | $1.87 Billion | ▼ -15.6% |
| 2008 | 0.28x | $2.07 Billion | $7.31 Billion | $2.07 Billion | ▼ -23.5% |
| 2007 | 0.37x | $2.14 Billion | $5.79 Billion | $2.14 Billion | ▼ -7.9% |
| 2006 | 0.40x | $1.59 Billion | $3.96 Billion | $1.59 Billion | ▲ +90.0% |
| 2005 | 0.21x | $1.18 Billion | $5.59 Billion | $1.18 Billion | ▲ +295.2% |
| 2004 | 0.05x | $255.00 Million | $4.77 Billion | $255.00 Million | ▼ -75.6% |
| 2003 | 0.22x | $1.06 Billion | $4.85 Billion | $1.06 Billion | ▼ -45.4% |
| 2002 | 0.40x | $1.23 Billion | $3.06 Billion | $1.23 Billion | ▲ +65.4% |
| 2001 | 0.24x | $1.12 Billion | $4.61 Billion | $1.12 Billion | ▼ -59.3% |
| 2000 | 0.60x | $1.10 Billion | $1.85 Billion | $1.10 Billion | ▼ -49.1% |
| 1999 | 1.17x | $597.00 Million | $510.00 Million | $597.00 Million | ▲ +1.0% |
| 1998 | 1.16x | $475.00 Million | $410.00 Million | $475.00 Million | ▲ +71.7% |
| 1997 | 0.67x | $415.00 Million | $615.00 Million | $415.00 Million | ▲ +42.9% |
| 1996 | 0.47x | $401.00 Million | $849.00 Million | $401.00 Million | ▼ -13.5% |
| 1995 | 0.55x | $684.00 Million | $1.25 Billion | $684.00 Million | ▲ +175.5% |
| 1994 | 0.20x | $485.59 Million | $2.45 Billion | $485.59 Million | ▼ -63.7% |
| 1993 | 0.55x | $575.00 Million | $1.05 Billion | $575.00 Million | ▼ -16.7% |
| 1992 | 0.66x | $608.00 Million | $927.00 Million | $608.00 Million | ▼ -27.5% |
| 1991 | 0.90x | $594.00 Million | $657.00 Million | $594.00 Million | ▼ -8.2% |
| 1990 | 0.99x | $606.00 Million | $615.00 Million | $606.00 Million | — |